GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Dr Hoenle AG (XTER:HNL) » Definitions » EBITDA Margin %

Dr Hoenle AG (XTER:HNL) EBITDA Margin % : 8.70% (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Dr Hoenle AG EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Dr Hoenle AG's EBITDA for the three months ended in Mar. 2024 was €2.1 Mil. Dr Hoenle AG's Revenue for the three months ended in Mar. 2024 was €24.3 Mil. Therefore, Dr Hoenle AG's EBITDA margin for the quarter that ended in Mar. 2024 was 8.70%.


Dr Hoenle AG EBITDA Margin % Historical Data

The historical data trend for Dr Hoenle AG's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Hoenle AG EBITDA Margin % Chart

Dr Hoenle AG Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.89 15.93 12.17 17.59 0.73

Dr Hoenle AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.89 -34.53 10.63 2.55 8.70

Competitive Comparison of Dr Hoenle AG's EBITDA Margin %

For the Electrical Equipment & Parts subindustry, Dr Hoenle AG's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Hoenle AG's EBITDA Margin % Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Dr Hoenle AG's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Dr Hoenle AG's EBITDA Margin % falls into.



Dr Hoenle AG EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Dr Hoenle AG's EBITDA Margin % for the fiscal year that ended in Sep. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Sep. 2023 )/Revenue (A: Sep. 2023 )
=0.779/106.342
=0.73 %

Dr Hoenle AG's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=2.117/24.321
=8.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dr Hoenle AG  (XTER:HNL) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Dr Hoenle AG EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Dr Hoenle AG's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr Hoenle AG (XTER:HNL) Business Description

Traded in Other Exchanges
Address
Nicolaus-Otto-Street 2, Gilching, Munich, BY, DEU, 82205
Dr Hoenle AG supplies industrial UV technology. It operates in three business segments: The Equipment and Systems segment, which accounts for the majority of revenue, includes devices for UVC air and surface disinfection, and it is used for drying inks and coatings, for curing adhesives and plastics, and for solar simulation. The Glass and Lamps segment includes the development, production, and sale of tubing and semi-finished goods made of quartz glass as well as the manufacture of UV medium?pressure and low-pressure lamps. Adhesives segment, which includes industrial adhesives designed for a broad spectrum of applications such as electronics, medical technology, optics, and glass processing. The company generates the majority of its revenue from sales in other countries.

Dr Hoenle AG (XTER:HNL) Headlines

No Headlines